Background. The achievement of quality of care constitutes a priority for modern health care systems. The objective of our study was to evaluate a quality improvement intervention in primary care of Cyprus.
Introduction
Primary health care systems in western societies are considered to have several limitations, which have extensively been discussed in the medical literature and remain a challenge even in the most advanced and generously funded systems. 1, 2 Furthermore, many reports refer to a general dissatisfaction expressed by patients with respect to the quality of care provided. 3 Concerns relate particularly to access and continuity of care, clinical effectiveness, patient safety, value for money and public accountability, all in which are covered under the term quality of care. 4 Thus, the majority of developed countries invest considerable resources on the continued improvement of quality of care.
In the last decade, a steady movement among health care services researchers, policy makers and other academics in the USA, Europe, New Zealand and Australia supports the systematic measurement of quality-of-care indicators. 5 In addition, such efforts are promoting reward schemes for effective primary care services including financial incentives. Particularly, in the UK, the introduction of the quality and outcome framework, 6 one of the most comprehensive initiatives in the above field, which forms the basis of quality measurement in UK primary care services, has shown quite promising results with major improvements in the quality of chronic disease management in general practice. 7, 8 However, experimental design and clinical trials are lacking in primary care practice in particular among countries where the discipline is less developed, including Greece and Cyprus. 9 Cyprus, a European Union and a Eurozone country, currently operates in a dual system of health care delivery. Thus, offering publicly funded health care services to low-and medium-income citizens, while the rest, mostly the wealthy part of the society, utilizes services from the private sector, covering their expenses either with private health insurance schemes or through out of pocket compensation. 10 Most of the public and private primary care settings have limited monitoring systems, under utilize contemporary information technologies and lack standardized care for the management of chronic diseases. 11 The Cyprus government has set, as an immediate national target, the introduction of a primary care-driven universal health care coverage system for the entire population, with quality improvement processes as an important incorporated component. At the moment, general practice in Cyprus remains underdeveloped, lacking a structural as well as a programmatic framework, and at the same time seeking recognition among the patients, the public and the medical society in general. It also falls behind in terms of systematic performance evaluation schemes and incentives to the primary care professionals.
Within an already existing framework of collaboration between the Clinic of Social and Family Medicine of the University of Crete and the Ministry of Health, a pilot intervention for quality improvement in two public primary health care centres (PHCC) in Cyprus was developed. The theoretical background of this programme, a detailed description of the study design to evaluate the intervention, and the motivation for choosing specific chronic diseases [i.e. diabetes and hypertension (HTN)] as target diseases, have been described elsewhere. 12 The objective of our current study was to evaluate a pilot multifaceted intervention to improve quality of care in patients with diabetes and HTN in public primary care centres of Cyprus.
Methods

Design
In a two-arm, non-randomized controlled study in public primary care centres in Cyprus, all patients with HTN and diabetes were invited. In one urban and one rural centre, a quality improvement programme was implemented; two other centres (one urban and one rural) served as control practices.
Setting
The study took place in Nicosia, the capital of Cyprus, in two urban and two rural public PHCC, which were selected based on the size of the population served and the number of practicing physicians. These selection criteria were chosen in order to create similar study groups, adequately representing the average primary care centre in Cyprus. All primary care physicians (PCPs), nurses and patients from the intervention centres (one urban and one rural) participated in the study as evaluators of the intervention, while all health care professionals and patients from another urban and rural centre in Cyprus served as controls, being observed to follow regular practice. The mean age of physicians providing care was 52 years (age range: 45-56 years) and for nurses was 40 years (age range: 31-44 years). Each centre had a worksite leader who would leverage resources and be the primary contact person in collaboration with the quality improvement team. 17 Participants and eligibility criteria All 19 117 paper-based medical records from all patients receiving care in the participating primary care centres were reviewed by the principal investigator and other trained health care professionals. Patients with HTN and Type II diabetes mellitus (T2DM) were identified by the investigators based on diagnoses documented in the medical records or appropriate documentation on standard anti-hypertensive and/or diabetes mellitus treatment. An independent crossexamination of random record review was also employed in order to secure a uniform application of selection criteria. Five hundred and thirty-nine patients, from the intervention and control group, with both co-morbid conditions (HTN and T2DM) were identified out of the 19 117 paper-based medical records reviewed. All eligible patients suffering concurrently with both T2DM and HTN were invited to participate in the study (Fig. 1) .
The multifaceted intervention
The multifaceted intervention mainly consisted of the introduction of an electronic medical record (EMR) system and chronic disease management guidelines. The EMR system was based on the International Classification System for Primary Care. At the intervention primary care centres, personal computers were introduced for all secretaries, nurses and physicians, along with a printer and a high-speed broadband Internet access for all. 13 The introduction and assessment of the EMR performance have been described elsewhere.
Chronic disease management guidelines served as our decision support tool, providing evidence-based clinical information to the health care professionals that were readily available through electronic databases facilitated by the EMR. 15 HTN management guidelines were based on the seventh Report of the Joint National Committee, 16 the European guidelines on cardiovascular disease (CVD) prevention 17 and the European Society of Hypertension-European Society of Cardiology Guidelines.
18 T2DM guidelines were based on the American Diabetes Association 19 and St Vincent Declaration 20 guidelines, whereas lipid control practice guidelines were based on the National Cholesterol Education Program III. 21 Additionally, the intervention involved several implementation strategies such as a combination of educational components (educational materials, workshops, local opinion leaders' presentations and academic detailing), audit and feedback and the introduction of an EMR system including a decision support system enabled through e-library and electronic reminders. Our project team consisted of two family physicians serving as programme facilitators, 22, 23 three academic experts in family medicine with extensive experience in quality improvement interventions and one family physician with expertise in EMR.
Outcome measures
The primary outcome measurement was improvement in the quality of care for two chronic diseases, HTN and T2DM, measured by specific quality indicators (QIs). QIs included specific and measurable elements of practice that can be used to assess the quality of care. 24 A set of QIs was developed by combining experts' opinion with current scientific evidence as presented in the guidelines on which our decision support tool was based (see above). HTN QIs included blood pressure (BP) measurement (systolic and diastolic), while lipid profile included measurements on total cholesterol (TC), high density lipoprotein-cholesterol (HDL-C), low density lipoproteincholesterol (LDL-C), and triglycerides, QIs for diabetes included: fasting blood glucose, levels of HbA1c, urine protein testing and dilated eye and foot examination. Additionally, patients' satisfaction was measured with the European Task Force on Patient Evaluations of General Practice (EUROPEP) questionnaire, which was distributed to all patients from the intervention and control primary care centres in order to evaluate patients' opinion before and after the intervention. 25 The EUROPEP instrument is a reliable and internationally validated questionnaire that measures patients' satisfaction with respect to the quality of care received http://fampra.oxfordjournals.org and the interpersonal skills of PCPs. The Greek version of the above questionnaire used in our study 26 was subjected to appropriate cultural adaptation for Cypriot patients with negligible changes.
Measurements
Measurements were undertaken before and after the intervention: (i) a baseline assessment (t = 0) and (ii) a follow-up comparison (t = 18 months). A window of 3 months run-in phase was implemented for the eligible patients in order to enter the study. Baseline measurements were considered up to the first 3 months from each patient's first visit. If a patient had more than one visit during the first 3 months, the mean value of those tests was calculated. The EUROPEP questionnaire was distributed to all patients before and after the intervention. Evaluation of the intervention included process and outcome evaluation. 27, 28 A detailed schematic description of the process and outcome evaluation plan has been published elsewhere. 12 
Statistical analysis
Statistical analyses were performed using SAS V9.1.3. Summary statistics were generated for baseline characteristics and clinical evaluations. t-Test and chi-square statistics were used to assess descriptive findings compared to baseline characteristics. The EUROPEP questionnaire was evaluated based on the mean values for each separate question from each group.
Results
Participants Thirty-five participants (6.5%) dropped out, died or were lost to follow-up, 16 participants in the intervention group (5.7%) and 19 participants in the control group (8.4%) with no significant differences between the two study groups with respect to age and sex. A total of 504 patients completed the study; 278 patients in the intervention group and 226 in the control group, respectively. Out of 504 participants, 301 were females (59%) and 203 were males (41%). The intervention group consisted of more male patients as compared to the control group (P = 0.035). In addition, there was a small difference in the mean age of the intervention (70.5 ± 8.7) compared to the control group (68.3 ± 9.9), respectively (P = 0.009). At baseline, there were no statistically significant differences in QIs between the intervention and the control group (Table 1) . Moreover, the percentage of subjects actually found to be at optimum clinical targets at baseline for TC, HDL-C, LDL-C, triglycerides, fasting blood glucose and HbA1c did not differ between the intervention and control group in a statistically significant fashion.
Intervention A comparison of QIs at the completion of the intervention period (t = 18 months) revealed statistically significant differences between the two groups. Specifically, at follow-up, the intervention group showed a 3.5 mmHg lower mean systolic BP (P = 0.0022) and 2.3 mmHg lower mean diastolic BP (P < 0.0001), a 1.1 mmol/l lower mean glucose compared to the control group (P < 0.0001), a 0.51 mmol/l lower mean TC (P < 0.0001), a 0.35 mmol/l lower mean LDL-C (P = 0.0022), respectively. However, no statistically significant differences were noted for mean HDL-C (P = 0.11), mean triglycerides (P = 0.82) and mean HbA1c (P = 0.32), respectively. The annual percentage of micro albumin/24-hour urine protein testing, the dilated eye examinations and the foot examinations increased from 0% to 37% (n = 103), 59% (n = 164) and 73% (n = 202), respectively. The comparisons were adjusted for age, gender, baseline values and number of visits to the primary care centres.
Patients' satisfaction
The EUROPEP questionnaire was distributed to 504 patients from both the intervention and the control groups before and after the intervention. A total of 359 participants completed the questionnaire before and after the intervention, resulting in a response rate of 71.2%. There was a statistically significant improvement of 10/23 items in the intervention group and a statistically significant decline of 20/23 items in the control group, suggesting an overall positive effect of the intervention on patients' satisfaction ( Table 2) .
Discussion
This pilot study examined a quality improvement intervention in patients with HTN and diabetes in the primary care settings of Cyprus. Whereas there were no statistical differences in the mean values of QIs at baseline, at follow-up, there were statistical differences between intervention and control groups for the mean values of systolic and diastolic BP, TC and LDL-C and fasting glucose levels, while no difference was seen on the mean values of the HbA1c. Patients' satisfaction (EUROPEP) improved in the intervention practices but decreased in the control group.
Our results present certain similarities with those reported by Maddigan SL et al. 29 It seems that HbA1c levels are more difficult to positively influence and may require longer intervention periods. However, lipid and BP lowering in T2DM patients is associated with substantial CVD risk benefits having the greatest weight of evidence in terms of the clinical benefits that accrue with optimal treatment.
30,31
Family Practice-an international journal A published systematic review of controlled trials evaluating the effectiveness of interventions for patients with diabetes 32 concluded that multifaceted interventions do lead to improvements in the process of care. However, the effect on patient outcomes remained less clear because such outcomes were rarely assessed. Additionally, Renders et al. observed that changes in organizational practice, such as enhancing the role of the nurse or implementing central computer systems that improve the delivery of complex packages of care, are likely to have an impact on the provision of care for a wide range of other conditions. Furthermore, there was a strong recommendation that future studies should address changes in overall CVD risk and changes in patient-centred outcomes. Another recent review on implementation strategies of CVD risk tables also concluded that promising strategies for patient selection and risk assessment seem to be teamwork, nurse led-clinics and integrated IT support. 33 In our study, strategies tailored with local needs were used. Finally, a recent report by Ryken van Bruggen et al. 34 also confirms the difficulty in changing patient outcomes, whereas Gabbay et al. 35 reported an effective nurse case management intervention on BP control in diabetic patients. In summary, although changing patient outcomes is difficult to achieve, most promising interventions seem to be multifaceted and consist of teamwork with a strong role for the nurse and with integrated IT support.
Strengths and limitations
Our findings should be treated with some caution since concerns can be raised on design and sample size. Those concerns have been considered and reported in detail elsewhere. 12 Additionally, the intervention was implemented in a small number of primary care centres and a small number of patients with few physicians and nurses, thus limiting our study's generalizability. Furthermore, the power of our pilot study also is limited by the small number of primary care centres participating in the intervention and control groups. Typically, cluster randomized trials should include 5-15 practices per group taking into account the intra-class correlation due to practice. 36 Moreover, our study was not a randomized doubleblind community-based controlled trial since the primary care centres were not selected randomly due to the broad diversity among each one in the population they served. Nevertheless, our before and after study design, along with the examination of concurrent controls and an 18-month post-intervention follow-up evaluation, served our purpose of implementing a rigorous study in a country with low research capacity in the primary care setting. 37 Finally, poor medication adherence and lack of treatment intensification frequently occur in diabetes patients who are above target levels for CVD risk factors 38 . Unfortunately, the above variable although most likely implemented through the introduction of clinical guidelines, was not specifically measured in our study. Therefore, we presented our results only in a descriptive fashion, omitting any comparison with advanced statistical methods. Our findings may serve as hypothesis generating and being indicative of the directionality of changes and potential improvements that may be observed in such interventions.
Interestingly, the analysis of the EUROPEP questionnaire revealed that Cypriot patients are generally very satisfied with the public primary care services they receive, with an average evaluation at the level of 'very good' at all primary care centres. However, we need to bear in mind that the young population, which is the most demanding part of the population with respect to quality standards in health care has not been well represented in our study population. Finally, in our study, we do not report on process evaluation although the positive impact on 10 out of 23 items of the EUROPEP instrument may imply a positive direction.
Implications
Our study could have significant implications in the forthcoming implementation of a National Health Care System in Cyprus as it is the first study reporting on methodologies of improving physicians' performance. 39 Information technology and QIs (performance measurement) constitute the cornerstone of the nationwide quality improvement efforts through the introduction of the new national health care system. Our study suggests that Cypriot physicians need to have access to simplified disease management guidelines, information technology tools (EMR) and measurement systems in order to improve their clinical effectiveness. Any quality improvement strategies that do not include such fundamental components may jeopardize the effectiveness of significant financial investments. 40 Especially, countries with limited capacity and resources available for the primary care development and/or serious cost containment issues should seriously grapple with Family Practice-an international journal effective interventions built on evidence-based approaches with the highest potential for cost savings. Finally, our pilot study is thought to be a useful implementation model for future efforts towards a universal adoption of EMR and chronic disease management guidelines in the primary care system of Cyprus and other countries. However, the observed quality improvement needs to be implemented and evaluated beyond a pilot setting in order to provide firm evidence with respect to its overall effectiveness.
Conclusions
In summary, we conclude that a multicomponent, provider-based and regionally tailored pilot intervention may enhance physician performance and improve patients' satisfaction in the primary care setting. Implementation of our pilot intervention in a wider scale project is needed in order to assess its potential to improve the quality of services provided to diabetic and HTN patients. Future evaluation efforts with higher number of primary care practices and larger population samples are expected to provide definitive evidence on the effectiveness of quality improvement interventions in the primary care settings of emerging national health care systems such as Cyprus.
